Page last updated: 2024-10-22

amitriptyline and Carcinoma, Ehrlich Tumor

amitriptyline has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calixto-Campos, C1
Zarpelon, AC1
CorrĂȘa, M1
Cardoso, RD1
Pinho-Ribeiro, FA1
Cecchini, R1
Moreira, EG1
Crespigio, J1
Bernardy, CC1
Casagrande, R1
Verri, WA1

Other Studies

1 other study available for amitriptyline and Carcinoma, Ehrlich Tumor

ArticleYear
The Ehrlich tumor induces pain-like behavior in mice: a novel model of cancer pain for pathophysiological studies and pharmacological screening.
    BioMed research international, 2013, Volume: 2013

    Topics: Amitriptyline; Animals; Behavior, Animal; Carcinoma, Ehrlich Tumor; Cell Proliferation; Disease Mode

2013